EDGAR Filing Agent Form List
CIK: 0001840315
Form Type:
Year
| Form | Filer/Owner | Description | Subject Company | Date | Actions |
|---|---|---|---|---|---|
| 4 | Ocumension Therapeutics | Statement of changes in beneficial ownership of securi... | Eyepoint Pharmaceuticals, Inc. | 01/16/2024 | |
| 144 | Ocumension Therapeutics | Filing for proposed sale of securities under Rule 144 | Eyepoint Pharmaceuticals, Inc. | 01/11/2024 | |
| 4 | Ocumension Therapeutics | Statement of changes in beneficial ownership of securi... | Eyepoint Pharmaceuticals, Inc. | 12/07/2023 | |
| 144 | Ocumension Therapeutics | Filing for proposed sale of securities under Rule 144 | Eyepoint Pharmaceuticals, Inc. | 12/05/2023 | |
| 144/A | Eyepoint Pharmaceuticals, Inc. | Amendment to Filing for proposed sale of securities un... | 05/26/2023 | ||
| 144/A | Eyepoint Pharmaceuticals, Inc. | Amendment to Filing for proposed sale of securities un... | 05/26/2023 |
